SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 651.80-0.3%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Biotechwantabe10/28/2022 8:47:01 AM
   of 3557
 
Performance highlights in Q3 - page 14
Ex-U.S. U.S.
1,549
2,314
511
Worldwide growth of +45% vs Q3 2021
Recent progress
• U.S. accelerated growth driven by AD 6 mo. + and EoE launches
Ex-U.S. annualizing to ~€2B
1,410
1,963 1,614
Ex-U.S. (+43%)1
349
1,061
378
1,171
438
1,176
486
1,477
1,803 U.S. (+45%)1
1,061 1,170
•
New approvals added 225k eligible patients in the last two quarter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News